About: Elusys Therapeutics

An Entity of Type: Private company, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Elusys Therapeutics is a biopharmaceutical company founded in Pine Brook, New Jersey in 1998. The company specializes in the development of antibodies for the treatment infectious diseases. The antibodies are developed from protein complexes called heteropolymers which can bind to specific pathogens on one side and red blood cells on the other side.

Property	Value
dbo:abstract	Elusys Therapeutics is a biopharmaceutical company founded in Pine Brook, New Jersey in 1998. The company specializes in the development of antibodies for the treatment infectious diseases. The antibodies are developed from protein complexes called heteropolymers which can bind to specific pathogens on one side and red blood cells on the other side. The pathogens will be dragged to the liver where they will be destroyed. The antibodies have a potential to be used for the treatments of many blood-borne diseases. Currently, the company focuses on the late-stage clinical trials of Anthim (Obiltoxaximab) to be used for treatment and prevention of inhaled anthrax. (en)
dbo:foundingYear	1998-01-01 (xsd:gYear)
dbo:headquarter	dbr:Pine_Brook,_Morris_County,_New_Jersey
dbo:type	dbr:Private_company
dbo:wikiPageExternalLink	http://www.elusys.com/%7Celusys.com
dbo:wikiPageID	48670320 (xsd:integer)
dbo:wikiPageLength	8191 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1061419536 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Private_company dbr:Defense_Advanced_Research_Projects_Agency dbr:Alliance_for_Biosecurity dbr:Hoffmann-La_Roche dbr:United_States_Army_Medical_Research_Institute_of_Infectious_Diseases dbr:United_States_Department_of_Health_and_Human_Services dbr:University_of_Texas_at_Austin dbr:University_of_Virginia dbr:Intramuscular_injection dbr:Intravenous_therapy dbr:Monoclonal_antibody dbr:Anthrax dbr:Lupus dbr:Board_of_directors dbr:Pathogen dbc:Pharmaceutical_companies_based_in_New_Jersey dbr:Food_and_Drug_Administration dbr:Bacillus_anthracis dbc:Companies_based_in_Morris_County,_New_Jersey dbr:Biopharmaceutical dbr:Bioterrorism dbr:Pine_Brook,_Morris_County,_New_Jersey dbr:Antibacterial dbr:National_Institutes_of_Health dbr:Obiltoxaximab dbr:Infectious_disease dbr:Strategic_National_Stockpile dbr:Venture_capital dbr:Biologics_License_Application
dbp:founded	1998 (xsd:integer)
dbp:hqLocation	dbr:Pine_Brook,_Morris_County,_New_Jersey
dbp:keyPeople	Dr. Elizabeth G. Posillico (en)
dbp:name	Elusys Therapeutics (en)
dbp:type	dbr:Private_company
dbp:website	http://www.elusys.com/%7Celusys.com
dbp:wikiPageUsesTemplate	dbt:Infobox_company dbt:Reflist
dct:subject	dbc:Pharmaceutical_companies_based_in_New_Jersey dbc:Companies_based_in_Morris_County,_New_Jersey
gold:hypernym	dbr:Company
rdf:type	owl:Thing dbo:Company schema:Organization dul:Agent dul:SocialPerson dbo:Agent wikidata:Q24229398 wikidata:Q43229 wikidata:Q4830453 dbo:Organisation
rdfs:comment	Elusys Therapeutics is a biopharmaceutical company founded in Pine Brook, New Jersey in 1998. The company specializes in the development of antibodies for the treatment infectious diseases. The antibodies are developed from protein complexes called heteropolymers which can bind to specific pathogens on one side and red blood cells on the other side. (en)
rdfs:label	Elusys Therapeutics (en)
owl:sameAs	yago-res:Elusys Therapeutics wikidata:Elusys Therapeutics https://global.dbpedia.org/id/264oE
prov:wasDerivedFrom	wikipedia-en:Elusys_Therapeutics?oldid=1061419536&ns=0
foaf:homepage	http://www.elusys.com/%7Celusys.com
foaf:isPrimaryTopicOf	wikipedia-en:Elusys_Therapeutics
foaf:name	Elusys Therapeutics (en)
is dbo:wikiPageWikiLink of	dbr:Bio-1 dbr:Alliance_for_Biosecurity dbr:Monoclonal_antibody_therapy dbr:Biomedical_Advanced_Research_and_Development_Authority dbr:Obiltoxaximab
is foaf:primaryTopic of	wikipedia-en:Elusys_Therapeutics